Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06824727 · ClinicalTrials.gov registry record
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 40
- Enrollment target
NCT06824727 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 40 participants.
The verdict
NCT06824727 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of the research project is to collect one blood sample from participants who are affected by very low platelets as a result of their condition or their treatment.
Interventions
- OTHER Baseline cell blood counts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2025-08-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06824727
The ClinicalTrials.gov registry entry for NCT06824727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baseline cell blood counts is the first listed.
NCT06824727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06824727 about?
NCT06824727 is a clinical study titled "Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia". The purpose of the research project is to collect one blood sample from participants who are affected by very low platelets as a result of their condition or their treatment.
What is the current status of trial NCT06824727?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2025-01-06. Estimated completion is 2025-08-21.
What interventions are being tested in trial NCT06824727?
The interventions under investigation include: Baseline cell blood counts (OTHER).
Who is sponsoring clinical trial NCT06824727?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.